dc.contributor.author | Ball, Thomas A. | eng |
dc.contributor.author | Kerns, J. William | eng |
dc.contributor.author | Nashelsky, Joan | eng |
dc.date.issued | 2003 | eng |
dc.description.abstract | Beta-blockers (class II antiarrhythmics) reduce sudden death and total mortality in patients with heart failure (strength of recommendation [SOR]: A, based on systematic reviews of randomized controlled trials). Amiodarone (class III) may reduce sudden death in heart failure (SOR: B, extrapolation from randomized controlled trials), but evidence is weak that it reduces total mortality, and it has significant side effects. Class I and other class III antiarrhythmic agents appear cause an increase in mortality due to sudden death in heart failure (SOR: B, extrapolations from randomized controlled trials). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/2912 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2003 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 52, no. 09 (September 2003): 719-721. | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | side effects | eng |
dc.subject | mortality | eng |
dc.subject | beta-blockers | eng |
dc.subject | ventricular arrhythmia | eng |
dc.subject.lcsh | Coronary heart disease | eng |
dc.subject.lcsh | Arrhythmia | eng |
dc.subject.lcsh | Adrenergic beta blockers | eng |
dc.subject.mesh | Arrhythmias, Cardiac | eng |
dc.title | Do antiarrhythmics prevent sudden death in patients with heart failure? | eng |
dc.type | Article | eng |